Akebia Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Akebia Therapeutics stock have an average target of 5.00, with a low estimate of 4.00 and a high estimate of 6.00. The average target predicts an increase of 270.37% from the current stock price of 1.35.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.00	$5.00	$6.00	$6.00
Change	+196.30%	+270.37%	+344.44%	+344.44%

* Price targets were last updated on Mar 28, 2024.

Analyst Ratings

The average analyst rating for AKBA stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '24	Mar '24	Apr '24	May '24	Jun '24	Jul '24
Strong Buy	2	2	2	2	2	2
Buy	1	1	1	1	1	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $5 → $6	Strong Buy	Maintains	$5 → $6	+344.44%	Mar 28, 2024
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5	Strong Buy	Reiterates	$5	+270.37%	Mar 15, 2024
Julian Harrison BTIG	BTIG	Strong Buy Initiates $4	Strong Buy	Initiates	$4	+196.30%	Nov 29, 2023
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $3.75 → $5	Strong Buy	Maintains	$3.75 → $5	+270.37%	Nov 17, 2023
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $3.75	Strong Buy	Reiterates	$3.75	+177.78%	Sep 27, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

175.99M

from 194.62M

-9.57%

from 194.62M

Revenue Next Year

162.57M

from 175.99M

-7.63%

from 175.99M

EPS This Year

-0.30

from -0.28

EPS Next Year

-0.33

from -0.30

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	335.00M	294.64M	211.65M	292.48M	194.62M	175.99M	162.57M	241.91M	334.00M	452.89M
Revenue Growth	61.26%	-12.05%	-28.17%	38.19%	-33.46%	-9.57%	-7.63%	48.80%	38.07%	35.60%
EPS	-2.36	-2.78	-1.70	-0.52	-0.28	-0.30	-0.33	0.15	0.53	1.11
EPS Growth	-	-	-	-	-	-	-	-	255.17%	111.65%
Forward PE	-	-	-	-	-	-	-	9.13	2.57	1.21
No. Analysts	-	-	-	-	-	5	5	4	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	189.5M	193.2M	252.4M	418.7M	653.0M
Avg	176.0M	162.6M	241.9M	334.0M	452.9M
Low	161.3M	123.4M	229.3M	251.1M	260.8M

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	-2.6%	9.8%	55.3%	73.1%	95.5%
Avg	-9.6%	-7.6%	48.8%	38.1%	35.6%
Low	-17.1%	-29.9%	41.0%	3.8%	-21.9%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	-0.21	0.08	0.43	0.58	1.75
Avg	-0.30	-0.33	0.15	0.53	1.11
Low	-0.36	-0.57	-0.12	0.47	0.50

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	-	-	-	290.5%	233.8%
Avg	-	-	-	255.2%	111.7%
Low	-	-	-	218.1%	-4.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.